Published in J Neurol on November 13, 2013
Cerebral amyloid angiopathy: emerging concepts. J Stroke (2015) 1.14
The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis. Biochim Biophys Acta (2015) 0.99
Clinical spectrum, underlying etiologies and radiological characteristics of cortical superficial siderosis. J Neurol (2015) 0.93
Prevalence of superficial siderosis following singular, acute aneurysmal subarachnoid hemorrhage. Neuroradiology (2014) 0.86
Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice. Trends Neurosci (2016) 0.81
Cortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy. Cerebrovasc Dis (2016) 0.80
Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population. Neurology (2016) 0.78
Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. Neurology (2017) 0.75
Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients. PLoS One (2015) 0.75
Stroke: an update. J Neurol (2014) 0.75
Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke. J Neurol (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med (2000) 3.23
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology (2000) 2.59
Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry (2011) 2.32
Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol (2010) 1.96
Superficial siderosis in the general population. Neurology (2009) 1.52
Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology (2013) 1.29
Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol (2012) 1.14
The brain in healthy aged individuals: MR imaging. Radiology (1990) 1.04
Superficial siderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol (2009) 0.76
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol (2013) 4.29
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet (2009) 4.11
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Cadasil. Lancet Neurol (2009) 3.88
Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol (2008) 3.75
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol (2011) 2.84
Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol (2013) 2.78
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol (2009) 2.55
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet (2007) 2.35
Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet (2010) 2.35
Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet (2009) 2.29
Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology (2012) 2.23
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch Gen Psychiatry (2004) 2.07
Anaesthetic management in patients with Duchenne muscular dystrophy undergoing orthopaedic surgery: a review of 232 cases. Eur J Anaesthesiol (2012) 2.07
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp Neurol (2003) 1.99
The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics (2010) 1.91
International experience, electives, and volunteerism in surgical training: a survey of resident interest. J Am Coll Surg (2007) 1.91
Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke (2005) 1.89
Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology (2014) 1.85
Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res (2006) 1.84
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial. Lancet Neurol (2013) 1.84
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke (2013) 1.80
Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain (2004) 1.78
Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected]. Cell Stem Cell (2013) 1.77
Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke (2012) 1.68
Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet (2012) 1.64
ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke (2005) 1.62
White matter integrity in the brains of professional soccer players without a symptomatic concussion. JAMA (2012) 1.58
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging (2011) 1.57
Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging (2012) 1.56
Mirror movements in healthy humans across the lifespan: effects of development and ageing. Dev Med Child Neurol (2010) 1.54
Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations. Stroke (2008) 1.52
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
Effects of gender on the phenotype of CADASIL. Stroke (2011) 1.47
Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke (2009) 1.46
Inhibition of interleukin-6-activated janus kinases/signal transducers and activators of transcription but not mitogen-activated protein kinase signaling in liver of endotoxin-treated rats. Crit Care Med (2002) 1.45
Single nucleotide polymorphisms associated with rat expressed sequences. Genome Res (2004) 1.43
Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment. Biol Psychiatry (2011) 1.43
Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol (2005) 1.42
Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain (2011) 1.41
Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain (2006) 1.38
Beyond herniation. Clin Neurol Neurosurg (2012) 1.38
Agenesis and dysgenesis of the corpus callosum: clinical, genetic and neuroimaging findings in a series of 41 patients. Am J Med Genet A (2008) 1.32
Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke (2010) 1.30
Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev (2004) 1.30
Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol (2013) 1.30
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease. Ann Neurol (2002) 1.29
Aging of human supraspinal locomotor and postural control in fMRI. Neurobiol Aging (2010) 1.29
Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet (2013) 1.27
Text mining and protein annotations: the construction and use of protein description sentences. Genome Inform (2006) 1.26
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke (2013) 1.25
Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain (2013) 1.25
Variation in the PDE4D gene and ischemic stroke risk: a systematic review and meta-analysis on 5200 cases and 6600 controls. Stroke (2008) 1.19
A high-density association screen of 155 ion transport genes for involvement with common migraine. Hum Mol Genet (2008) 1.17
Biological marker candidates of Alzheimer's disease in blood, plasma, and serum. CNS Neurosci Ther (2009) 1.17
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol Neurodegener (2010) 1.15
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol (2012) 1.14
Association of SORL1 gene variants with Alzheimer's disease. Brain Res (2009) 1.14
Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study. Stroke (2012) 1.14
The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry (2005) 1.13
Divergent sodium channel defects in familial hemiplegic migraine. Proc Natl Acad Sci U S A (2008) 1.13
Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging (2008) 1.13
Irradiation and bevacizumab in high-grade glioma retreatment settings. Int J Radiat Oncol Biol Phys (2010) 1.12
Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain (2009) 1.12
Diverse functional consequences of mutations in the Na+/K+-ATPase alpha2-subunit causing familial hemiplegic migraine type 2. J Biol Chem (2008) 1.11
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation (2014) 1.11
Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL. Stroke (2007) 1.10
An interdisciplinary initiative to reduce radiation exposure: evaluation of appendicitis in a pediatric emergency department with clinical assessment supported by a staged ultrasound and computed tomography pathway. Acad Emerg Med (2009) 1.10
Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology (2010) 1.09
Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans. Stroke (2008) 1.09
Ischemic stroke of the cortical "hand knob" area: stroke mechanisms and prognosis. J Neurol (2009) 1.08
The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online. Hum Mutat (2007) 1.08
Drip, ship, and retrieve: cooperative recanalization therapy in acute basilar artery occlusion. Stroke (2010) 1.07
Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis. Anal Chem (2008) 1.06
17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status. Stroke (2013) 1.04
Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. Comb Chem High Throughput Screen (2005) 1.04